Brazil, Cuba in bioscience R&D talks
This article was originally published in Clinica
Executive Summary
Brazil and Cuba were this week engaged in discussions aimed at completing a series of co-operation agreements in the fields of healthcare surveillance and product development, among other things. As part of an official visit to Havana by Brazilian president Luis Inacio Lula da Silva, a team headed by health minister Jose Gomes Temporao and the director of healthcare surveillance agency Anvisa, Dirceu Raposo de Mello, discussed a range of areas of planned co-operation, from bioscientific manufacturing to product standards and QA.
You may also be interested in...
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.